You have 9 free searches left this month | to do more
Showing 1 - 25 of
>10,000 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
DC Vaccination in CML
Recruiting
  • Myeloid Leukemia, Chronic
  • DC vaccine
  • Berlin, Germany
  • +1 more
2021-08-03
Aug 3, 2021
E
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
Not yet recruiting
  • Chronic Myeloid Leukemia
  • (no location specified)
2022-03-30
Mar 30, 2022
S
Dose Reduced Dasatinib (70 mg Daily) as First-line Treatment for Newly Diagnosed CML-CP
Recruiting
  • Dasatinib
  • +2 more
  • Shenzhen, Guangdong, China
    Xin Du
2022-03-15
Mar 15, 2022
G
Myeloid Mutations Register in R/R CML
Recruiting
  • Chronic Myeloid Leukaemia Recurrent
  • Chronic Myeloid Leukemia, in Relapse
  • Myeloid mutations measurement
  • Huixquilucan, Estado De México, Mexico
    Grupo Cooperativo de Hemopatías Malignas
2021-10-04
Oct 4, 2021
M
ASTX727 and Dasatinib for the Treatment of Newly Diagnosed Philadelphia Chromosome or BCR-ABL Positive Chronic Myeloid Leukemia in Chronic Phase
Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-12-29
Dec 29, 2021
M
Dasatinib and Venetoclax in Treating Patients With Philadelphia Chromosome Positive or BCR-ABL1 Positive Early Chronic Phase Chronic Myelogenous Leukemia
Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
2022-01-19
Jan 19, 2022
A
Gleevec as Maintenance Therapy After Cytogenetic Response With Nilotinib in Newly Diagnosed Chronic Myelogenous Leukemia
Recruiting
  • Chronic Myelogenous Leukemia
  • Beirut, Lebanon
    American University of Beirut Medical Center
2022-02-14
Feb 14, 2022
N
Flumatinib Efficacy and Safety for New Diagnosed Chronic Phase Chronic Myeloid Leukemia
Recruiting
  • Validity and Safety
    • Guangzhou, Guangdong, China
      NanfangH
    2021-09-02
    Sep 2, 2021
    I
    Randomized Evaluation of Radotinib Versus Imatinib in Phase III Study for Efficacy With Chinese Patients (RERISE China)
    Active, not recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Beijing, China
      Peking University People's Hospital(北京大学人民医院)
    2022-01-03
    Jan 3, 2022
    A
    FLOR3 Gene Polymorphism in Predicting Outcomes of Tyrosine Kinase Inhibitor（TKI）Stopping in Chronic Myeloid Leukemia
    Recruiting
    • Folate
    • +2 more
      • Nantong, China
        Affliated Hospital of Nantong University
      2021-12-13
      Dec 13, 2021
      L
      IIT PH1 KDS-1001 in Patients With CML
      Not yet recruiting
      • CML (Chronic Myelogenous Leukemia
      • (no location specified)
      2021-11-29
      Nov 29, 2021
      U
      Italian Treatment Free Remission Registry
      Recruiting
      • Treatment Free Remission
      • Chronic Myeloid Leukemia
        • Turin, Italy
          Division of Hematology-AO Mauriziano Hospital, University of Tur
        2021-11-17
        Nov 17, 2021
        N
        Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitor in Patients With Chronic Myeloid Leukemia
        Not yet recruiting
        • Tyrosine Kinase Inhibitor
        • +2 more
          • Taipei, Taiwan
            National Taiwan University Hospital
          2022-02-17
          Feb 17, 2022
          M
          Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment - 2021
          Completed
          • Chronic Myelogenous Leukemia, BCR-ABL Positive
          • CML, Chronic Phase
          • Pioglitazone 15mg
          • Mansoura, Dakahlia, Egypt
            Faculty of Medicine
          2021-05-11
          May 11, 2021
          W
          Stem Cell Monitoring for CML Patients Undergoing Nilotinib Therapy - 2021
          Completed
          Has Results
          • Chronic Myeloid Leukemia
          • New York, New York
            Weill Cornell Medical College
          2022-03-24
          Mar 24, 2022
          M
          Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
          Recruiting
          • Chronic Myelogenous Leukemia
          • Chart Review
          • Houston, Texas
            University of Texas MD Anderson Cancer Center
          2022-02-08
          Feb 8, 2022
          H
          Cognitive Behavioral Intervention for Targeted Therapy Fatigue (CBT-TTF) Intervention - 2021
          Completed
          Has Results
          • Chronic Myelogenous Leukemia
          • Therapy for Targeted Therapy-related Fatigue (TTF)
          • Wait-List Control Condition (WLC)
          • Tampa, Florida
            H. Lee Moffitt Cancer Center and Research Institute
          2021-11-15
          Nov 15, 2021
          U
          Observational Study on Chronic Myeloid Leukemia Patients in Any Phase Treated With Ponatinib (Iclusig®) at Any Dose
          Recruiting
          • Chronic Myeloid Leukemia, Chronic Phase
            • Jena, Germany
              University Hospital Jena
            2021-08-12
            Aug 12, 2021
            x
            A Study for PRO of CML in Real Word
            Recruiting
            • CML (Chronic Myelogenous Leukemia)
            • questionnaire
            • Guanzhou, China
              Department of Hematology, Nanfang Hospital, Southern Medical Uni
            2021-10-11
            Oct 11, 2021
            O
            Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant
            Recruiting
            • Acute Myeloid Leukemia
            • +6 more
            • Hyperbaric oxygen
            • Rochester, New York
              Wilmot Cancer Institute, University of Rochester
            2022-01-12
            Jan 12, 2022
            A
            TIGIT in Patients With Chronic Myeloid Leukemia
            Not yet recruiting
            • Chronic Myeloid Leukemia
            • flow cytometry test
            • (no location specified)
            2021-03-25
            Mar 25, 2021
            C
            Interest of PHARMaceutical Conciliation to Understand Drug Interactions, Phytotherapy, and Targeted Therapies in Chronic Myeloid Leukemia
            Recruiting
            • Chronic Myeloid Leukemia
            • Pharmaceutical intervention
            • Saint-Étienne, France
              CHU de Saint-Etienne
            2022-02-24
            Feb 24, 2022
            U
            A Distress Reduction Intervention for Patients With BCR-ABL-Negative MPNs or CML on Tyrosine Kinase Inhibitors
            Recruiting
            • Myeloproliferative Neoplasm
            • +2 more
            • Online Mindfulness Meditation
            • Internet-Based Webinars
            • San Francisco, California
              University of California San Francisco
            2022-02-22
            Feb 22, 2022
            M
            Omega -3 Fatty Acid in Combination With Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia - 2021
            Terminated
            • Chronic Myeloid Leukemia, Chronic Phase
            • Eicosapentaenoic Acid
            • Tyrosine kinase inhibitor
            • Hershey, Pennsylvania
              Penn State Cancer Institute
            2021-10-04
            Oct 4, 2021
            M
            ABL001 + Dasatinib + Prednisone in BCR-ABL+ B-ALL or CML
            Recruiting
            • B-cell Acute Lymphoblastic Leukemia
            • +2 more
            • Chicago, Illinois
            • +5 more
            2021-12-27
            Dec 27, 2021